Injective, a DeFi-centric protocol, integrates with Fetch.ai and the Artificial Superintelligence Alliance (ASI) after a proposal passed with unanimous support. This integration allows Fetch.ai to plug AI and machine learning capabilities into the Injective platform, enhancing AI-enabled trading tools and improving liquidity management.
Despite this promising partnership, INJ's prices have declined. The cryptocurrency's value saw a dip of 20% from October highs, with prices consolidating at the $10 level. Resistance and support are marked at $25 and $15, respectively. This downtrend occurs despite higher highs during the weekend's trading sessions.
Overall, Injective's high revenue-to-fully diluted valuation (FDV) ratio showcases efficient revenue generation, which is likely to contribute to an upside in prices. Improved crypto sentiment and increasing total value locked across DeFi could further benefit INJ prices once the market rally resumes.
